Test Your Knowledge of HCM and Learn More About Mavacamten
Join Matthew W. Martinez, MD, FACC; Michael J. Ackerman, MD, PhD, FACC; and Erica Spatz, MD, for Real-World Shared Decision Making Conversations: Sudden Cardiac Death in HCM in Stop 5: HCM Shared Decision Making: Conversations That Count. Improve your skills in recognizing, diagnosing and treating HCM and test your knowledge with the final quiz, HCM Guidelines Case Challenges. Plus, join our expert faculty for a three-part CardiaCast Podcast series as they discuss what clinicians should know about the newly approved cardiac myosin inhibitor, Mavacamten, which patients can benefit, and its mechanisms of action. Accelerate your path to HCM diagnosis and treatment with practical, tangible solutions with this free online course. Learn more.